CASI Pharmaceuticals

CASI Pharmaceuticals(CASIF)

BEIJING, China
Pharmaceutical
WebsiteLinkedInCareers Page

Focus: Small Molecules

CASI Pharmaceuticals is a life sciences company focused on Small Molecules.

Neurology
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT00904787Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies
Phase 1
Phase 1
Clinical Trials (1)
NCT00658671A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
Phase 1
Phase 1
Clinical Trials (1)
NCT00806065Study of ENMD-2076 in Patients With Multiple Myeloma
Phase 1
melphalan hydrochloride for injection
Multiple Myeloma
Phase 1
Clinical Trials (1)
NCT05438394Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM
Phase 1
Phase 1
Clinical Trials (1)
NCT00506402A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
Phase 1
Phase 1
Clinical Trials (1)
NCT04758767CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
Phase 1
Phase 1
Clinical Trials (1)
NCT00656461Phase 1 Study of MKC-1 in Patients With Advanced Cancer
Phase 1
Phase 1/2
Clinical Trials (1)
NCT07017725A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT00408226Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
Phase 1/2
Panzem Nanocrystal Colloidal Dispersion
Recurrent Glioblastoma Multiforme
Phase 2
Clinical Trials (1)
NCT00306618Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
Phase 2
recombinant human Angiostatin protein
Carcinoma, Non-Small-Cell Lung
Phase 2
Clinical Trials (1)
NCT00049790Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT01104675Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT01639248Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
Phase 2
Phase 2
Clinical Trials (1)
NCT00481455Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
Phase 2
Panzem® NCD
Prostate Cancer
Phase 2
Clinical Trials (1)
NCT00394810Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT02234986A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Phase 2
Phase 2
Clinical Trials (1)
NCT00444314Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
Phase 2
Phase 2
Clinical Trials (1)
NCT00568646Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT00328497A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
Phase 2
Phase 2
Clinical Trials (1)
NCT00607607A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
Phase 2
Panzem Nanocrystal Colloidal Dispersion
Ovarian Cancer
Phase 2
Clinical Trials (1)
NCT00400348Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
Phase 2
2-methoxyestradiol
Relapsed Multiple Myeloma
Phase 2
Clinical Trials (1)
NCT00592579A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
Phase 2
Phase 2
Clinical Trials (1)
NCT00306631A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
Phase 2
Melphalan Hydrochloride for Injection
Multiple Myeloma
Phase 4
Clinical Trials (1)
NCT06425276Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 24 clinical trials